Publicaciones en las que colabora con María Guembe (43)

2024

  1. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 435-438

  2. Impact of an interventional bundle on complications associated with peripheral venous catheters in elderly patients

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 703-712

  3. Impact of the COVID-19 pandemic on the incidence and the epidemiology of catheter-related bloodstream infection two years later

    Heliyon, Vol. 10, Núm. 14

  4. The endoscopy department can alert to complications associated with peripheral venous catheters in patients admitted to a tertiary teaching hospital

    Heliyon, Vol. 10, Núm. 17

  5. Vascular catheter-related infections: an endemic disease in healthcare institutions. An opinion paper of the Spanish Society of Cardiovascular Infections (SEICAV)

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 5, pp. 387-400

2022

  1. A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

    Infectious Diseases and Therapy, Vol. 11, Núm. 2, pp. 743-755

  2. Correction to: A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing (Infectious Diseases and Therapy, (2022), 11, 2, (743-755), 10.1007/s40121-021-00579-4)

    Infectious Diseases and Therapy

  3. Production of biofilm by Staphylococcus aureus: Association with infective endocarditis?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 8, pp. 418-422

2021

  1. Endotracheal tubes coated with a broad-spectrum antibacterial ceragenin reduce bacterial biofilm in an in vitro bench top model

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 5, pp. 1168-1173

  2. How should microbiology laboratories interpret cultures of the sonicate of closed needleless connectors?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 2, pp. 72-77

2020

  1. In Vitro Study to Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 12

  2. Randomized clinical trial analyzing maintenance of peripheral venous catheters in an internal medicine unit: Heparin vs. saline

    PLoS ONE, Vol. 15, Núm. 1

  3. Selective digestive decontamination solution used as "lock therapy" prevents and eradicates bacterial biofilm in an in vitro bench-top model

    Annals of clinical microbiology and antimicrobials, Vol. 19, Núm. 1, pp. 44

  4. What does really affect the colonization of needleless connectors?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 3, pp. 97-98

2019

  1. Correction: Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model(PLOS ONE(2019) 14:8(e0221702)DOI:10.1371/journal.pone.0219098)

    PLoS ONE

  2. Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model?

    PLoS ONE, Vol. 14, Núm. 7

2018

  1. Biofilm production is not associated with poor clinical outcome in 485 patients with Staphylococcus aureus bacteraemia

    Clinical Microbiology and Infection, Vol. 24, Núm. 6, pp. 659.e1-659.e3

  2. Impact of a training program on adherence to recommendations for care of venous lines in internal medicine departments in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 37, Núm. 6, pp. 1163-1168

  3. In vitro assessment of the anti-biofilm activity of ethanol alone and in combination with enoxaparin 60 IU

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 10, pp. 627-632

  4. The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study

    Journal of Hospital Infection, Vol. 100, Núm. 3, pp. e187-e195